Unlocking Hansa Investment Company
Hansa Investment Company looks cheap given that it could eventually restructure, says Max King.

Winston Churchill described Russia as “a riddle, wrapped in a mystery, inside an enigma”. The same could be said of the £370m Hansa, listed and managed in London but registered in Bermuda, which has been connected to the Salomon family since the 1950s.
To most professional investors, Hansa is opaque, distrusted and unpredictable. One third of the 120 million shares are voting shares (LSE: HAN) and two thirds (LSE: HANA) are non-voting. A little over half the voting shares are connected to the Salomon family, of which half are attributed to William Salomon, a director of Hansa and managing partner of its fund manager. He also owns nearly 5% of the non-voting shares and has been buying recently.
Both the voting and non-voting shares are trading at a discount to net asset value (NAV) of more than 30% and expectations of the sort of corporate change that would reduce this are low. Shorter term that is probably correct, but not so longer term.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Struggling in Brazil
About 21% of Hansa’s NAV is attributable to its 26% holding in Ocean Wilsons, a listed holding company (Salomon family interests hold another 25% of Ocean Wilsons directly). Half of Ocean Wilsons’ valuation is due to its portfolio of investment funds and half to its 58% holding in Wilson Sons, a logistics and marine services business operating and listed in Brazil.
Alec Letchfield, investment manager of Hansa since 2014, describes Wilson Sons as “a really good company in a very difficult market”. Brazil – famously “the country of tomorrow and always will be” – has been in turmoil since 2008. Wilson Sons has struggled on, but it has accounted for a falling proportion of Hansa’s assets.
In better times, Wilson Sons will prosper, its valuation will rise and hence so will the valuation of Ocean Wilsons, which currently trades on a discount to its own NAV of about a third.
A respectable performance
The remaining 79% of Hansa is performing creditably: 43% is invested in core regional funds and about 12% in each of global equities, thematic funds and diversifying funds. The performance of the global-equities portfolio has been disappointing in recent years – having been “too value orientated”, says Letchfield – but has picked up recently. The core regional funds have performed broadly in line with global indices, but the thematic funds, comprising healthcare, biotech, disruptive growth and environmental, have far out-performed. The diversifying funds have lagged in the last year, but did exceptionally well in the two prior years.
These equity-heavy allocations could change if Letchfield becomes more cautious, but at present he is relaxed. “We expect a powerful recovery, abundant liquidity and central banks to err on the side of caution,” he says. He remains a long-term bull on the US (57% of the investment portfolio) due to “its ability to tackle problems and rejuvenate itself”. Turnover in funds is low, although turnover of direct holdings is greater.
Closing the discount
Hansa aims to be comparable with RIT Capital Partners, capturing most of the upside of equity markets, but limiting the downside. This would require changes. Few believe the Salomons would ever agree to the sale of Wilson Sons, but that’s probably wrong. Doing so would turn Ocean Wilsons into a pure investment firm, which could be merged with Hansa.
With share buy-backs and perhaps enfranchisement of Hansa’s non-voting shares, the discount to NAV could fall from nearly 40% on a look-through basis to 10%, giving the shares upside of nearly 50%. The possibility of an exit from Brazil makes it worth locking away at the current bargain price.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Max has an Economics degree from the University of Cambridge and is a chartered accountant. He worked at Investec Asset Management for 12 years, managing multi-asset funds investing in internally and externally managed funds, including investment trusts. This included a fund of investment trusts which grew to £120m+. Max has managed ten investment trusts (winning many awards) and sat on the boards of three trusts – two directorships are still active.
After 39 years in financial services, including 30 as a professional fund manager, Max took semi-retirement in 2017. Max has been a MoneyWeek columnist since 2016 writing about investment funds and more generally on markets online, plus occasional opinion pieces. He also writes for the Investment Trust Handbook each year and has contributed to The Daily Telegraph and other publications. See here for details of current investments held by Max.
-
Why CEOs deserve a pay rise
Opinion The CEOs of big companies often come under fire for being grossly overpaid. But the truth, as per some economists, is the opposite. Do they merit a pay rise?
By Stuart Watkins Published
-
Europe prepares to stand alone as Trump turns on Ukraine
Support for old military alliances is wavering in the US under Donald Trump. Europe’s leaders are rushing to fill the void. Simon Wilson reports
By Simon Wilson Published
-
Why CEOs deserve a pay rise
Opinion The CEOs of big companies often come under fire for being grossly overpaid. But the truth, as per some economists, is the opposite. Do they merit a pay rise?
By Stuart Watkins Published
-
Rolls-Royce stock jumps 15% – could it climb further?
Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
By Dr Matthew Partridge Published
-
The power of private markets
Interview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
By Andrew Van Sickle Published
-
Vertex Pharmaceuticals is an uncommon opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success
By Dr Mike Tubbs Published
-
Global investors have overlooked these top tips in emerging markets
Opinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
By Chris Tennant Published
-
King Coal has not been dethroned yet — should you buy?
The demand for coal is only growing, yet investors don’t seem to want to take advantage of the opportunity, says Rupert Hargreaves
By Rupert Hargreaves Published
-
It’s time to start buying Europe again, says Merryn Somerset Webb
Opinion Europe's stocks are cheap and the economic backdrop is starting to look cheerier, says Merryn Somerset Webb
By Merryn Somerset Webb Published
-
Prosus to buy Just Eat for €4.1 billion as takeaway boom fades
Food-delivery platform Just Eat has been gobbled up by a Dutch rival. Now there could be further consolidation in the sector
By Dr Matthew Partridge Published